Cheryl Cohen

Insider Reports History

Identity 1 fact
Location
Hampton, NJ
SEC filing record 1 fact
SEC signature
/s/ Jason Liljestrom, as Attorney-in-Fact
SEC evidence 1 fact
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Cheryl Cohen:

Form 4 holding Director

ImmunityBio, Inc.

Security class
Stock Option (right to buy)
Shares / value
162,786
Estimated value
Report date
18 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

MEI Pharma, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
87,500
Estimated value
Report date
05 Jul 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Celldex Therapeutics, Inc.

Security class
Non-Qualified Stock Option (right to buy)
Shares / value
16,500
Estimated value
Report date
13 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Cheryl Cohen

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .